Serum microRNA-125a-5p, a useful biomarker in liver diseases, correlates with disease progression

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 1584-1590

  Zheng, Jianjian ^a   Zhou, Zhenxu ^b   Xu, Ziqiang ^a   Li, Guojun ^c   Dong, Peihong ^a   Chen, Zhanguo ^a   Lin, Dezhao ^d   Chen, Bicheng ^a   Yu, Fujun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b Department of Laparoscopic Surgery ^*  (China)

^c Second Hospital of Ningbo   (China)

^d Wenzhou Hospital of Traditional Chinese Medicine   (China)

Author keywords

Biomarker; Hepatocellular carcinoma; Liver fibrosis; Serum microRNA 125a 5p

Indexed keywords

MICRORNA; MICRORNA 125A 5P; UNCLASSIFIED DRUG; MIRN125 MICRORNA, HUMAN;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BLOOD LEVEL; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HEPATITIS B; HISTOLOGICAL ACTIVITY INDEX SCORE; HUMAN; KAPLAN MEIER METHOD; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; VIRUS REPLICATION; AGED; BIOSYNTHESIS; BLOOD; GENE EXPRESSION REGULATION; LIVER CIRRHOSIS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 84926648388     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3546     Document Type: Article

References (30)

1. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
2. Li L, Guo Z, Wang J, Mao Y and Gao Q: Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci 57: 2910-2916, 2012.
3. Ding J, Huang S, Wu S, et al: Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399, 2010.
4. Bi Q, Tang S, Xia L, et al: Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PloS One 7: e40169, 2012.
5. Coppola N, Potenza N, Pisaturo M, et al: Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PLoS One 8: e65336, 2013.
6. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
7. Fang C, Zhu DX, Dong HJ, et al: Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Annals Hematol 91: 553-559, 2012.
8. Gilad S, Meiri E, Yogev Y, et al: Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148, 2008.
9. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
10. Kim KH, Kim ND and Seong BL: Discovery and development of anti-HBV agents and their resistance. Molecules 15: 5878-5908, 2010.
11. Liu X, Wan X, Li Z, Lin C, Zhan Y and Lu X: Golgi protein 73 (GP73), a useful serum marker in liver diseases. Clin Chem Lab Med 49: 1311-1316, 2011.
12. Chen CJ, Yang HI, Su J, et al: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73, 2006.
13. 2004 guidelines for surgical treatment of primary hepatocellular carcinoma. Chinese Journal of Hepatology 13: 329-330, 2005.
14. Ishak K, Baptista A, Bianchi L, et al: Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699, 1995.
15. Yao J, Liang L, Huang S, et al: MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 51: 846-856, 2010.
16. Lau DT and Bleibel W: Current status of antiviral therapy for hepatitis B. Therap Adv Gastroenterol 1: 61-75, 2008.
17. Bayram A, Erkilic S, Ozkur A, Bayram M and Sari I: Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology. J Clin Pathol 61: 338-342, 2008.
18. Yuen MF, Ng IO, Fan ST, et al: Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol 99: 2032-2037, 2004.
19. European Association For The Study Of The Liver: EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50: 227-242, 2009.
20. Russo A and Potenza N: Antiviral effects of human microRNAs and conservation of their target sites. FEBS Lett 585: 2551-2555, 2011.
21. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V and Russo A: Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 39: 5157-5163, 2011.
22. Park SO, Kumar M and Gupta S: TGF-beta and iron differently alter HBV replication in human hepatocytes through TGF-beta/BMP signaling and cellular microRNA expression. PloS One 7: e39276, 2012.
23. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K and Kawada N: Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 412: 74-79, 2011.
24. Vizzutti F, Arena U, Rega L and Pinzani M: Non invasive diagnosis of portal hypertension in cirrhotic patients. Gastroenterol Clin Biol 32: 80-87, 2008.
25. Xie SB, Yao JL, Zheng RQ, Peng XM and Gao ZL: Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int 2: 69-72, 2003.
26. Parsian H, Rahimipour A, Nouri M, et al: Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. J Gastrointestin Liver Dis 19: 169-174, 2010.
27. Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S and Diamantis I: Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int 26: 864-871, 2006.
28. Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C and Bell BP: National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis 5: A74, 2008.
29. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
30. Qi P, Cheng SQ, Wang H, Li N, Chen YF and Gao CF: Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 6: e28486, 2011.